---
title: "300 Seed Biotech Investors (Nov 2026)"
last_updated: "2026-11-09"
rows: "300"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/seed-biotech-investors/"
---

# 300 seed biotech investors

We list 300 seed biotech investors as of November 2026: 161 have an SEC filing on file and 139 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (65), New York (14) and Massachusetts (14).

- 300 investors
- 148 with a fund filing or dated deal in the last 12 months
- $71M median fund size on file (SEC Form D, 112 firms)
- 1,458 named decision-makers on file

## First 25 of 300 seed biotech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Biotech, Healthtech, Medtech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/hatteras-venture-partners/ |
| ARCH Venture Partners | VC firm | Chicago, IL | Pre-seed, Seed | Biotech, Healthtech, Deep Tech | New fund, Aug 2026 | $3.0B (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/arch-venture-partners/ |
| Future Ventures | VC firm | Los Altos, CA | Seed | Biotech, Healthtech, AI, Energy | New fund, Oct 2026 | $200M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/future-ventures/ |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-innovation-capital/ |
| Breakout Ventures | VC firm | San Francisco, CA | Seed | Biotech, AI, Healthtech, Industrial Tech | New deal, Jun 2026 | $112M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/breakout-ventures/ |
| Digitalis Ventures | VC firm | New York, NY | Seed | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Biotech, Healthtech, Medtech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/gore-range-capital/ |
| Aisling Capital | VC firm | New York, NY | Seed | Biotech, Healthtech, Food and Beverage, Medtech | Portfolio news, Jul 2026 | $64M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/aisling-capital/ |
| First In Ventures | VC firm | Hobe Sound, FL | Pre-seed, Seed | Biotech, Healthtech, AI, Climate Tech | New fund, Sep 2026 | $22M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/first-in-ventures/ |
| Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Biotech, Healthtech, Deep Tech, AI | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-angels/ |
| Narya | VC firm | Columbus, OH | Seed | Biotech, Fintech, Healthtech, Defense Tech | New fund, Sep 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/narya/ |
| Thirdrockventures | VC firm | Boston, MA | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Jun 2026 | $1.1B (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/thirdrockventures/ |
| Two Bear Capital | VC firm | Whitefish, MT | Seed | Biotech, Healthtech, AI, Deep Tech | New fund, May 2026 | $123M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/two-bear-capital/ |
| Rapha Capital Management, LLC | VC firm | Surfside, FL | Seed | Biotech, Healthtech, Medtech | New deal, Jun 2026 | $10M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/rapha-capital-management-llc/ |
| Safar Partners | VC firm | Cambridge, MA | Seed | Biotech, Healthtech, Industrial Tech, Deep Tech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/safar-partners/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Biotech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Sep 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/nlc-fund-management-b-v/ |
| Start Codon | Accelerator | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI | Portfolio news, Nov 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/start-codon/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Biotech, Healthtech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/shd-partners/ |
| NSV | VC firm | Greenwich, CT | Seed, Late stage | Biotech, Healthtech, AI, Semiconductor | Portfolio news, Oct 2026 | $990M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/nsv/ |
| Epidarex Capital | VC firm | Edinburgh, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Jul 2026 | $17M (SEC Form ADV) | 2026-11-04 | https://theinvestordatabase.com/investors/epidarex-capital/ |
| XISTA Science Ventures | VC firm | Klosterneuburg, Austria | Pre-seed, Seed | Biotech, Deep Tech, AI, Industrial Tech | Portfolio news, Oct 2026 | €96M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/xista-science-ventures-management-gmbh-2/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Biotech, Medtech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |

You are seeing 25 of 300. The full list adds 275 more investors and 1,458 named decision-makers.

Get all 300 investors and 1,458 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/seed-biotech-investors
This page: https://theinvestordatabase.com/lists/seed-biotech-investors/

## Method and limits
- Source: 161 of the 300 rows carry an SEC filing (Form D or Form ADV). All 300 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at seed.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 300 rows: stage 300, sector 300, fund size 194, website 300. In the paid file: named decision-makers on 279 rows, firm email on 147, LinkedIn page on 195, check size on 74.

## Questions
### How many seed biotech investors are there?
We list 300 as of November 2026. 148 of the 300 have a fund filing or a dated deal in the last 12 months.

### Which seed biotech investors raised a new fund in the last 12 months?
61 of the 300 have a fund filing dated in the last 12 months. The most recent on this list are Future Ventures (Oct 2026), Draper Associates (Oct 2026) and Pear Ventures (Oct 2026).

### What is the typical fund size of seed biotech investors?
The median fund size on file for this list is $71M, across the 112 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 188 do not disclose a size there.

### How do I contact seed biotech investors?
The paid file holds 1,458 named decision-makers across 279 of these 300 and a firm email for 147. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on seed biotech investors come from?
161 of the 300 rows have an SEC filing on file (Form D or Form ADV) and 139 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.